1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control

COVIDpandemic has changed clinical practice in Primary and Hospital Care. Chronic Diseases Care have been relegated after COVID19, emergencies and severe pathologies (cancer) Elderly patients with DM2 had less access to medical services due to COVIDprotocols. HbA1c is important to manage patients with DM2. Between COVIDwaves and specially in 2021 there was a program to recover Diabetic Care in our 250000 inhabitants Health Department, specially most frail elderly patients with DM2

Aim: Find out if Elderly patients with DM2 chronic care was reduced during the COVIDpandemic period and if that affected their diabetic control.

Methodology: HbA1c tests taken to patients with DM2 and > 70 year between January 20 and November 2021 were obtained as they are all done in our hospital either from Primary or Hospital Care. Data was calculated by Mean Monthly Number HbA1c tests (MMNHT) during prepandemic: March 20to February 2020, pandemic: March 2020 to February 2021 and postpandemic: March 2021 to November 2021. Diabetic control was calculated in three groups: % HbA1c <7%; 7-8% and > 8% of all tests done in those three periods.

Results: MMNHT had increased by 5% annually and a trend to better diabetic control was seen since 20until 2019. MMNHT were prepandemic vs. pandemic: 1313 vs. 10 (- 22.5%) and pandemic vs. postpandemic: 10vs. 1334 (+ 31%) % . Those changes were similar in Primary and Hospital Care.%HbA1c 7; 7-8 and > 8% was in prepandemic: 50, 31 and 19%; pandemic: 50, 30 and 20% and postpandemic: 67, 28 and 11%.

Summary: During COVIDpandemic, Elderly patients with DM2 had less chronic medical care as had a 23% reduction of MMNHT although it did recover posteriorly. Protocols to identify and recover diabetic chronic care in patients > 70 year might be helpful in our experience. Diabetic control was similar before, during and after the COVIDpandemic period: March 2020 to February 2021.